ValuEngine upgraded shares of Streamline Health Solutions (NASDAQ:STRM) from a hold rating to a buy rating in a research report sent to investors on Thursday, ValuEngine reports.
Separately, TheStreet upgraded shares of Streamline Health Solutions from a d rating to a c- rating in a research note on Thursday, January 9th.
NASDAQ:STRM traded down $0.01 during mid-day trading on Thursday, hitting $1.21. The stock had a trading volume of 54,218 shares, compared to its average volume of 74,764. Streamline Health Solutions has a twelve month low of $0.81 and a twelve month high of $2.09. The stock has a market cap of $37.81 million, a price-to-earnings ratio of -6.42 and a beta of 0.15. The company’s 50 day simple moving average is $1.30 and its 200 day simple moving average is $1.31.
Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Wednesday, January 8th. The company reported ($0.01) earnings per share (EPS) for the quarter. Streamline Health Solutions had a negative net margin of 16.61% and a negative return on equity of 2.21%. The firm had revenue of $5.79 million during the quarter.
In other Streamline Health Solutions news, insider David Driscoll sold 26,213 shares of the firm’s stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $1.32, for a total transaction of $34,601.16. Following the completion of the sale, the insider now directly owns 187,500 shares in the company, valued at $247,500. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 24.28% of the company’s stock.
Hedge funds have recently modified their holdings of the business. Alera Investment Advisors LLC acquired a new stake in Streamline Health Solutions during the third quarter worth approximately $113,000. Vanguard Group Inc. lifted its position in Streamline Health Solutions by 53.3% during the second quarter. Vanguard Group Inc. now owns 177,001 shares of the company’s stock worth $267,000 after acquiring an additional 61,550 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its position in Streamline Health Solutions by 2.4% during the second quarter. Renaissance Technologies LLC now owns 351,250 shares of the company’s stock worth $530,000 after acquiring an additional 8,300 shares during the last quarter. Hedge funds and other institutional investors own 29.17% of the company’s stock.
About Streamline Health Solutions
Streamline Health Solutions, Inc provides health information technology solutions and services for hospitals and health systems in the United States and Canada. It provides software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights to its clients.
Read More: What is a capital gain?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.